New Delhi: India’s pharmaceutical industry is taking proactive measures to combat the rising Human Metapneumovirus (HMPV) cases. With the country reporting several instances of HMPV infection, the industry is gearing up to develop diagnostic kits and treatments to fight the virus. Dr. Aravind Badiger Technical Director of BDR Pharmaceuticals spoke about the same considering the government’s response and the pharma industry’s preparedness.
Government Support and Preparedness
The Indian government has assured citizens that there is no need to panic, emphasizing that HMPV is not a new virus, this was first found in the Netherlands in 2001. This virus has been circulating globally. The government has also confirmed that the health systems and surveillance networks are alert and prepared to respond promptly to emerging health challenges.
Pharmaceutical Industry’s Response
The Indian pharmaceutical industry is a significant player in the global market. The industry is now focusing on innovation to become the healthcare custodian of the world. With its expertise in producing high-quality, affordable generic drugs and vaccines, India is poised to play a crucial role in combating HMPV.
Development of Diagnostic Kits and Treatments
Several Indian pharmaceutical companies are working on developing diagnostic kits that can detect HMPV quickly and accurately. These kits will enable healthcare professionals to diagnose the virus early, which is critical for effective treatment. Additionally, companies are working on developing new treatments for HMPV, including antiviral medications, immunomodulators, and supportive care therapies.
Public Health Advice
The government has urged citizens to remain alert and adopt preventive measures such as maintaining good respiratory hygiene, wearing masks in crowded places, social distancing, and seeking medical attention if respiratory symptoms persist. This virus is said to be spread through droplets. The importance of strengthening immunity through proper nutrition and vaccination against other respiratory illnesses has also been emphasised.
Conclusion
In conclusion, India’s pharmaceutical industry is taking proactive measures to combat HMPV, with the government’s support and preparedness. The industry’s focus on innovation and expertise in producing affordable generic drugs and vaccines, positions India to play a crucial role in the global fight against HMPV.
The Indian pharmaceutical industry is a significant player in the global market. The industry is now focusing on innovation to become the healthcare custodian of the world. With its expertise in producing high-quality, affordable generic drugs and vaccines, India is poised to play a crucial role in combating HMPV. Health News Health News: Latest News from Health Care, Mental Health, Weight Loss, Disease, Nutrition, Healthcare
